Background
People with HIV (PWH) are at elevated risk for type 2 diabetes (T2D), despite viral suppression. While obesity is a well-known driver of T2D in the general population, HIV-specific factors, such as chronic inflammation and antiretroviral therapy (ART), may contribute to risk in PWH. While subcutaneous adipose tissue (SAT) fibrosis promotes insulin resistance in obesity, less is known about its role in HIV, and whether it has a distinct tissue transcriptomic profile in this setting.
Methods
We studied 112 participants (43 ART-suppressed PWH and 69 without HIV) matched for BMI, age, sex, and hemoglobin A1c, from UCSF cohorts, stratified by %body fat (%BF) by DEXA (high: >35% women, >25% men). SAT fibrosis was assessed with tissue hydroxyproline (HP) levels, insulin resistance by HOMA-IR, and plasma endotrophin (a collagen VIalpha3 posttranslational cleavage product with potent pro-fibrotic activity) by ELISA. Transcriptomic analysis of SAT was performed using a Nanostring panel of 772 fibrosis-related genes.
Results
PWH had more SAT fibrosis (by HP levels) than those without HIV (P<0.01), particularly among those [n=17] with normal %BF (median 68 vs 439, P=< 0.01), suggesting that the excess SAT fibrosis in PWH is not solely due to increased adiposity. In PWH, SAT fibrosis correlated more strongly with HOMA-IR in those with normal %BF (r=0.70, P<0.01) than in those with high %BF (r=0.38, p=0.07). Plasma endotrophin levels were also higher in PWH than controls (p<0.05), and positively correlated with HOMA-IR (r=0.35, p<0.01) and HP levels (r=0.34, P=0.03) in PWH. In transcriptomic analysis, PWH had a unique obesity-independent upregulation of genes such as COL14A1, which stabilizes collagen, and CSF1R, which supports myeloid cell differentiation and whose ligand (CSF1) is associated with increased mortality in treated HIV (Figure 1). In contrast, both HIV and high %BF induced upregulation of inflammatory mediators like CCL4 and NLRP3, highlighting some shared transcriptional pathways between obesity and HIV.
Conclusions
PWH have increased SAT fibrosis, even at normal %BF, which is characterized by obesity-independent transcriptional changes. Upregulation of COL14A1 in PWH may play a pivotal role in promoting SAT fibrosis and associated metabolic dysfunction while CSF1R upregulation may suggest an important role of macrophage differentiation. Furthermore, SAT fibrosis in PWH is predictive of insulin resistance at normal %BF and can be assessed noninvasively via plasma endotrophin levels.
Table or Figure
![]()